Sunshine Biopharma, Inc. (NasdaqCM:SBFM) announces a share repurchase program. Under the program, the company will repurchase up to $2 million worth of its shares. As of November 7, 2022, the company had approximately 22,600,000 shares of common stock issued and outstanding.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 USD | -1.81% | -5.05% | -98.78% |
05-21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
05-20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.78% | 7.91M | |
+62.10% | 856B | |
+38.95% | 631B | |
-3.92% | 359B | |
+15.55% | 325B | |
+9.29% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+16.14% | 177B | |
+2.38% | 165B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Sunshine Biopharma, Inc. announces an Equity Buyback for $2 million worth of its shares.